UNSPSC 51283213: Mirosamicin

This classification denotes a macrolide antibiotic with the molecular formula C37H61NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K7G02HKM1X, chemically known as 4,17-dioxabicyclo(14.1.0)heptadeca-6,14-diene-5,13-dione, 2-(((6-deoxy-2,3-di-o-methyl-beta-d-allopyranosyl)oxy)methyl)-3-ethyl-2-hydroxy-8,10,12-trimethyl-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-d-xylo-hexopyranosyl)oxy)-, (1r,2s,3r,6e,8s,9s,10s,12r,14e,16s)- but generally known as mirosamicin, which bears US NIH Compound Identifier 6436150.

UNSPSC 51283213 Mirosamicin is a Commodity code that nominally describes a specific macrolide antibiotic, but recent state and local solicitation activity under this code does not align with procurement of mirosamicin itself. Instead, the opportunities tagged to this code reflect broader pharmaceutical and medical supply purchasing by state health agencies, counties, and municipalities — including naloxone acquisition, generic multi-source pharmaceuticals through cooperative purchasing vehicles, direct-to-manufacturer prescription programs, and emergency medical supplies for fire and rescue operations. State and local issuers soliciting under this code include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon participants). The scope of actual procurement spans both branded and generic pharmaceuticals, OTC products, emergency medical consumables, and naloxone distribution systems acquired through fixed-price contracts, cooperative agreements, and RFI-stage market intelligence gathering.

Recent activity concentrates in Florida and Minnesota, with additional solicitation in Texas and multistate cooperative reach. The Seminole County Fire Rescue Division IFB (IFB60459723LAS, response due July 26, 2026) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option. The City of Tampa's IFB (26P00145, response due March 13, 2026) targeted 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000.00, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance RFP (S1070000015802, response due March 26, 2026) sought generic multi-source pharmaceuticals and OTC products through three authorized wholesalers with a two-year contract term effective July 1, 2026, and the Texas HHS Commission issued an RFI (HHS0017013, response due April 3, 2026) to gather vendor capabilities for a proposed Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The mismatch between the code's nominal scope and actual buying activity suggests this code sees little relevant procurement in its primary category.